Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e29e8934838be2b5bd2772f4038fca6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a39e9717f56322318e4ddb037a59ed2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d2a0b887515bc238d55b4233c668ff3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c5d79504afcf76c9dfa15825a758e572 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7909ed3cf82f0dfdd4dd6cb69f1c4f15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_559ec3960c545c6b9f01db728ad39dba http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c77d885e071e40bcb26714d0250c0bd |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-22 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D9-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-22 |
filingDate |
1999-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fef58c972f3b2361eacf76eedc535bf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36d688572890b5a4d50164987b2a4347 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf3c5605941aba95d223c6f9f4ca3d0d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e45e1d46ae8869e260ae112f017dd978 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_432adf63ee93914b9e99cf52669ee7a7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7df2607373837128cdbf015b473c8fd |
publicationDate |
2000-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-0027804-A1 |
titleOfInvention |
Method for the crystallization of iopamidol |
abstract |
Disclosed is the crystallization of Iopamidol using a mixture of an alcohol and water as a crystallization solvent. The ratios of water:Iopamidol from 1:10 to 1:1 (v/w) and alcohol:Iopamidol from 1:1 to 1:10 (v/w) allow Iopamidol to be crystallized to an anhydrous pure form with industrially valuable yields without producing monohydrates and pentahydrates. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007073202-A1 |
priorityDate |
1998-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |